In this issue:
Dapagliflozin in patients with CKD
Cardiovascular and renal outcomes with empagliflozin in heart failure
Cardiovascular outcomes with ertugliflozin in type 2 diabetes
Two-year trial of belimumab in lupus nephritis
Outcomes of kidney transplants from older deceased donors in the UK
Treatments for restless legs syndrome in ESKD
Sodium polystyrene sulphonate and GI adverse events in advanced CKD
Efficacy and safety of oral tolvaptan in patients undergoing haemodialysis
Changes in blood pressure and arterial haemodynamics after living kidney donation
Laughter therapy in patients undergoing haemodialysis
Please login below to download this issue (PDF)